Skip to main content

Articles

Page 6 of 12

  1. Given the global trend of aging societies, medical expenditure has hit record highs in many countries. Because medical advice-seeking behaviors can affect the health of whole societies, how members of a societ...

    Authors: Shih Han Lin and Tom M. Y. Lin
    Citation: Cost Effectiveness and Resource Allocation 2018 16:65
  2. Key performance indicators are essential navigation tools for hospitals. They provide managers with valid information enabling them to identify institutional strengths and weaknesses and improve managerial per...

    Authors: Kimia Pourmohammadi, Nahid Hatam, Payam Shojaei and Peivand Bastani
    Citation: Cost Effectiveness and Resource Allocation 2018 16:64
  3. Sex workers have high incidences of HIV and other sexually transmitted diseases. Although, interventions targeting sex workers have shown to be effective, evidence on which strategies are most cost-effective i...

    Authors: Giulia Rinaldi, Aliasghar A. Kiadaliri and Hassan Haghparast-Bidgoli
    Citation: Cost Effectiveness and Resource Allocation 2018 16:63
  4. The effectiveness of long lasting insecticidal nets (LLINs) and indoor residual spraying (IRS), for malaria prevention, have been established in several studies. However, the available evidence about the addit...

    Authors: Alemayehu Hailu, Bernt Lindtjørn, Wakgari Deressa, Taye Gari, Eskindir Loha and Bjarne Robberstad
    Citation: Cost Effectiveness and Resource Allocation 2018 16:61
  5. Malaysia has been experiencing an escalation in dengue cases since the past 5 years. As the dengue vaccine pipeline continues to develop steadily with strong public interests, this study had been sought to eli...

    Authors: Hui Yee Yeo and Asrul Akmal Shafie
    Citation: Cost Effectiveness and Resource Allocation 2018 16:60
  6. Road safety has been receiving increased attention through the United Nations Decade of Action on Road Safety, and is also now specifically addressed in the sustainable development goals 3.6 and 11.2. In an ef...

    Authors: Ambinintsoa H. Ralaidovy, Abdulgafoor M. Bachani, Jeremy A. Lauer, Taavi Lai and Dan Chisholm
    Citation: Cost Effectiveness and Resource Allocation 2018 16:59
  7. To study cost-effectiveness of an interleukin (IL)-17A inhibitor secukinumab, with other biologics and apremilast in patients with Psoriatic arthritis (PsA) from payer perspective in Finland.

    Authors: Timo Purmonen, Kari Puolakka, Devarshi Bhattacharyya, Minal Jain and Janne Martikainen
    Citation: Cost Effectiveness and Resource Allocation 2018 16:56
  8. The alarming increase in the cost of cancer care is forcing all stakeholders to re-evaluate their approach to treatment. Drugs are the main contributor to the cost. To evaluate the significance of drug substit...

    Authors: Yifan Xu, Joel W. Hay and Afsaneh Barzi
    Citation: Cost Effectiveness and Resource Allocation 2018 16:30
  9. Multiple technologies, procedures and programs call for fairly-based decisions for prioritization of healthcare interventions. There is a diversity of perspectives of what constitutes a legitimate decision, wh...

    Authors: Mireille M. Goetghebeur and Marjo S. Cellier
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):54

    This article is part of a Supplement: Volume 16 Supplement 1

  10. Decision making in health requires the use of sound evidence and context-specific information, guided by a priority setting methodology or framework. For noncommunicable disease (NCD) prevention and control, a...

    Authors: Silvana Luciani and Anselm Hennis
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):53

    This article is part of a Supplement: Volume 16 Supplement 1

  11. Priority setting in a climate of diverse needs and limited resources is one of the most significant challenges faced by health care policymakers. This paper develops and applies a comprehensive multi-criteria ...

    Authors: Rashmi Dayalu, Elizabeth T. Cafiero-Fonseca, Victoria Y. Fan, Heather Schofield and David E. Bloom
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):52

    This article is part of a Supplement: Volume 16 Supplement 1

  12. Multiple criteria decision analysis (MCDA) has been proposed as a method for determining the criteria to be used in health technology assessment. A standard criticism of MCDA is that it lacks attention to secu...

    Authors: Norman Daniels
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):51

    This article is part of a Supplement: Volume 16 Supplement 1

  13. Multi-criteria decision analysis (MCDA) has the potential to increase the consistency, transparency and rigour with which these criteria inform decisions. Political context is relevant not only as a motivation...

    Authors: Victoria Y. Fan
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):50

    This article is part of a Supplement: Volume 16 Supplement 1

  14. Cost–benefit and cost-effectiveness analysis place limits on the dimensions of value that the models can incorporate. Cost–benefit analysis requires monetization of all measures of value (including life), a ta...

    Authors: Charles Phelps and Guruprasad Madhavan
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):48

    This article is part of a Supplement: Volume 16 Supplement 1

  15. All healthcare systems face problems of justice and efficiency related to setting priorities for allocating limited financial resources. Therefore, explicit decision-making in healthcare depicted as a continuu...

    Authors: Héctor E. Castro, Ornella Moreno-Mattar and Juan C. Rivillas
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):47

    This article is part of a Supplement: Volume 16 Supplement 1

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2020 18:42

  16. As a country with significant resource constraints, a fair and efficient health priority setting should be at the cornerstone of Ethiopia’s commitment to attain universal health coverage by 2035. This paper dr...

    Authors: Mahlet Kifle Habtemariam and Sentayehu Tsegaye Semegn
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):46

    This article is part of a Supplement: Volume 16 Supplement 1

  17. Multi-criteria decision analysis (MCDA) is a structured decision-making process that offers greater flexibility to incorporate multiple objectives than cost-effectiveness analysis or benefit–cost analysis.

    Authors: Mark Jit
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):45

    This article is part of a Supplement: Volume 16 Supplement 1

  18. This comment argues that four critical questions needs to be resolved before MCDA tools can improve priority setting in health: how to merge the quantitative and deliberative elements of MCDA; how to select cr...

    Authors: Ole F. Norheim
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):44

    This article is part of a Supplement: Volume 16 Supplement 1

  19. Multicriteria decision analysis (MCDA) has the potential to bring more structure and transparency to health technology assessment (HTA). The objective of this paper is to highlight key methodological and pract...

    Authors: Kevin Marsh, Praveen Thokala, Sitaporn Youngkong and Kalipso Chalkidou
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):43

    This article is part of a Supplement: Volume 16 Supplement 1

  20. Rotavirus (RV) diarrhea is the most common cause of severe diarrhea in children worldwide and since 2006, vaccines have been available and recommended by WHO for use in all children. We developed protocols tha...

    Authors: Roger I. Glass
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):42

    This article is part of a Supplement: Volume 16 Supplement 1

  21. Preference-based social welfare functions (pbSWF) perform better at reconciling competing personal and social goals than typical forms of MCDA. Its virtues are (a) its respect for people’s own judgments about ...

    Authors: J. P. Sevilla
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):41

    This article is part of a Supplement: Volume 16 Supplement 1

  22. Prioritization in healthcare is particularly sensitive to subjective biases and data asymmetry. Yet making data-based and objective decisions are critical to optimizing long term individual and societal benefi...

    Authors: Michael Watson
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):40

    This article is part of a Supplement: Volume 16 Supplement 1

  23. This commentary utilizes the lens of public opinion research in health to suggest ideas for best integrating public input into multi-criteria decisions analysis (MCDA) approaches. The field of public opinion r...

    Authors: Gillian K. SteelFisher
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):39

    This article is part of a Supplement: Volume 16 Supplement 1

  24. This brief perspective highlights the importance of decision maker buy-in and ownership through stakeholder engagement in the co-construction of the multi-criteria decision analysis (MCDA) model. A brief histo...

    Authors: Praveen Thokala and Guruprasad Madhavan
    Citation: Cost Effectiveness and Resource Allocation 2018 16(Suppl 1):0

    This article is part of a Supplement: Volume 16 Supplement 1

  25. The costs for treating coronary artery disease (CAD) are high worldwide. We performed a prespecified analyses of cost-effectiveness of three therapeutic strategies for multivessel CAD.

    Authors: Sara Michelly Gonçalves Brandão, Paulo Cury Rezende, Hans-Peter Brunner-La Rocca, Yang Ting Ju, Antonio Carlos Pedroso de Lima, Myrthes Emy Takiuti, Whady Hueb and Edimar Alcides Bocchi
    Citation: Cost Effectiveness and Resource Allocation 2018 16:55
  26. Following the adoption of the Global Action Plan for the Prevention and Control of NCDs 2013–2020, an update to the Appendix 3 of the action plan was requested by Member States in 2016, endorsed by the Seventi...

    Authors: Ambinintsoa H. Ralaidovy, Chaitra Gopalappa, André Ilbawi, Carel Pretorius and Jeremy A. Lauer
    Citation: Cost Effectiveness and Resource Allocation 2018 16:38
  27. While the world has made much global progress toward the reduction of new HIV infections, HIV continues to be an important public health problem. In the face of constantly constrained resources, donors and gra...

    Authors: S. Bautista-Arredondo, N. Nance, A. Salas-Ortiz, D. Akeju, A. G. Oluwayinka, I. Ezirim, J. Anenih, C. Chima, O. Amanze, G. Omoregie, K. Ogungbemi and S. H. Aliyu
    Citation: Cost Effectiveness and Resource Allocation 2018 16:37
  28. Respiratory Medication Therapy Adherence Clinic (RMTAC) is an initiative by the Ministry of Health (MOH) Malaysia to improve patients’ medication adherence, as an adjunct to the usual physician care (UC). This...

    Authors: Yee Vern Yong and Asrul Akmal Shafie
    Citation: Cost Effectiveness and Resource Allocation 2018 16:36
  29. Specialist palliative care in the hospital addresses a heterogeneous patient population with complex care needs. In Germany, palliative care patients are classified based on their primary diagnosis to determin...

    Authors: Christian Becker, Reiner Leidl, Eva Schildmann, Farina Hodiamont and Claudia Bausewein
    Citation: Cost Effectiveness and Resource Allocation 2018 16:35
  30. The choice of cost data sources is crucial, because it influences the results of cost studies, decisions of hospital managers and ultimately national directives of policy makers. The main objective of this stu...

    Authors: Abdelbaste Hrifach, Christell Ganne, Sandrine Couray-Targe, Coralie Brault, Pascale Guerre, Hassan Serrier, Hugo Rabier, Gwen Grguric, Pierre Farge and Cyrille Colin
    Citation: Cost Effectiveness and Resource Allocation 2018 16:34
  31. Midostaurin (MIDO) has been proposed for the treatment of newly-diagnosed adult patients with FMS-like tyrosine kinase 3 mutation-positive (FLT3+) acute myeloid leukemia (AML) in combination with standard chem...

    Authors: Gabriel Tremblay, Mike Dolph, Sachin Patel, Patricia Brandt and Anna Forsythe
    Citation: Cost Effectiveness and Resource Allocation 2018 16:33
  32. Hypertension represents a high burden of disease in different healthcare systems. Recent guideline published in 2017 by the American Heart Association and the American College of Cardiology has generated a deb...

    Authors: Cesar Augusto Guevara-Cuellar, Victoria Eugenia Soto and María Isabel Molina-Echeverry
    Citation: Cost Effectiveness and Resource Allocation 2018 16:32
  33. Sufficient and sustainable financing of the health system is essential for improving the health of the community. The health systems financing of the EMR countries is facing the challenge. Assessment and ranki...

    Authors: Kimia Pourmohammadi, Payam Shojaei, Hamed Rahimi and Peivand Bastani
    Citation: Cost Effectiveness and Resource Allocation 2018 16:31
  34. Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally. In China, sorafenib and oxaliplatin plus infusional-fluorouracil/leucovorin (FOLFOX4) are approved for the systemic treatmen...

    Authors: Shukui Qin, Eliza Kruger, Seng Chuen Tan, Shuqun Cheng, Nanya Wang and Jun Liang
    Citation: Cost Effectiveness and Resource Allocation 2018 16:29
  35. Human monoclonal antibody ustekinumab is a novel Crohn’s disease (CD) treatment blocking pro-inflammatory cytokines interleukin-12 and 23. The study’s objective was to assess cost-effectiveness of ustekinumab ...

    Authors: Amanda Hansson-Hedblom, Chrissy Almond, Fredrik Borgström, Indeg Sly, Dana Enkusson, Anders Troelsgaard Buchholt and Linda Karlsson
    Citation: Cost Effectiveness and Resource Allocation 2018 16:28
  36. Evidence on the relative costs and effects of interventions that do not consider ‘real-world’ constraints on implementation may be misleading. However, in many low- and middle-income countries, time and data s...

    Authors: Fiammetta M. Bozzani, Don Mudzengi, Tom Sumner, Gabriela B. Gomez, Piotr Hippner, Vicky Cardenas, Salome Charalambous, Richard White and Anna Vassall
    Citation: Cost Effectiveness and Resource Allocation 2018 16:27
  37. The current health system reforms in Kosovo aim to improve health status through universal health coverage. Risk pooling and ensuring access to necessary care without financial hardship are envisaged through c...

    Authors: Fatime Arenliu Qosaj, Guenter Froeschl, Merita Berisha, Bashkim Bellaqa and Rolf Holle
    Citation: Cost Effectiveness and Resource Allocation 2018 16:26
  38. A variety of mobile-based health technologies (mHealth) have been developed for use by community health workers to augment their performance. One such mHealth intervention—ReMiND program, was implemented in a ...

    Authors: Shankar Prinja, Pankaj Bahuguna, Aditi Gupta, Ruby Nimesh, Madhu Gupta and Jarnail Singh Thakur
    Citation: Cost Effectiveness and Resource Allocation 2018 16:25
  39. There are limited data describing the cost-effectiveness of brief interventions for substance use in resource-poor settings. Using a patient and provider perspective, this study investigates the cost-effective...

    Authors: Rebecca Dwommoh, Katherine Sorsdahl, Bronwyn Myers, Kwaku Poku Asante, Tracey Naledi, Dan J. Stein and Susan Cleary
    Citation: Cost Effectiveness and Resource Allocation 2018 16:24
  40. Translating prognostic and diagnostic biomarker candidates into clinical applications takes time, is very costly, and many candidates fail. It is therefore crucial to be able to select those biomarker candidat...

    Authors: Gimon de Graaf, Douwe Postmus, Jan Westerink and Erik Buskens
    Citation: Cost Effectiveness and Resource Allocation 2018 16:23
  41. Cardiovascular disease (CVD) is the leading cause of deaths globally, with greatest premature mortality in the low- and middle-income countries (LMIC). Many of these countries, especially in sub-Saharan Africa...

    Authors: Leopold Ndemnge Aminde, Noah Fongwen Takah, Belen Zapata-Diomedi and J. Lennert Veerman
    Citation: Cost Effectiveness and Resource Allocation 2018 16:22
  42. Previous studies have showed that the early diagnosis of threatened preterm labor decreases neonatal morbidity and mortality, avoids maternal morbidity induced by antepartum bed rest and unnecessary treatment,...

    Authors: Thomas Desplanches, Catherine Lejeune, Jonathan Cottenet, Paul Sagot and Catherine Quantin
    Citation: Cost Effectiveness and Resource Allocation 2018 16:21
  43. Colorectal cancer is one of the most common cancers worldwide and is associated with high mortality when detected at a later stage. There is a paucity of studies from low and middle income countries to support...

    Authors: Nelya Melnitchouk, Djøra I. Soeteman, Jennifer S. Davids, Adam Fields, Joshua Cohen, Farzad Noubary, Andrey Lukashenko, Olena O. Kolesnik and Karen M. Freund
    Citation: Cost Effectiveness and Resource Allocation 2018 16:20
  44. Health-care utilities differ considerably from country to country. Our objective was to examine the association of cultural values based on Hofstede’s cultural dimensions’ theory with utility values that were ...

    Authors: Jörg Mahlich, Piyameth Dilokthornsakul, Rosarin Sruamsiri and Nathorn Chaiyakunapruk
    Citation: Cost Effectiveness and Resource Allocation 2018 16:19
  45. Cost-effectiveness analysis (CEA) is frequently used as an input for guiding priority setting in health. However, CEA seldom incorporates information about trade-offs between total health gains and equity impa...

    Authors: Marie-Anne Boujaoude, Andrew J. Mirelman, Kim Dalziel and Natalie Carvalho
    Citation: Cost Effectiveness and Resource Allocation 2018 16:18
  46. Cost-effectiveness of once-daily umeclidinium bromide (UMEC) was compared with once-daily tiotropium (TIO) and once-daily glycopyrronium (GLY) in patients with chronic obstructive pulmonary disease (COPD) from...

    Authors: Dhvani Shah, Maurice Driessen, Nancy Risebrough, Timothy Baker, Ian Naya, Andrew Briggs and Afisi S. Ismaila
    Citation: Cost Effectiveness and Resource Allocation 2018 16:17

Annual Journal Metrics